Rapt Therapeutics, Inc. (RAPT)
34.00
+0.78
(+2.35%)
USD |
NASDAQ |
Dec 16, 16:00
34.00
0.00 (0.00%)
After-Hours: 17:25
Rapt Therapeutics Free Cash Flow: -86.66M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Replimune Group, Inc. | -269.69M |
| Olema Pharmaceuticals, Inc. | -134.67M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.46M |
| Cash from Investing (Quarterly) | 8.466M |
| Cash from Financing (Quarterly) | 0.036M |
| Free Cash Flow Per Share (Quarterly) | -0.462 |
| Free Cash Flow to Equity (Quarterly) | -11.89M |
| Free Cash Flow to Firm (Quarterly) | -12.46M |
| Free Cash Flow Yield | -3.23% |